Key result
AF catheter ablation yields similar 1-year success and complication rates in patients aged ≥75 vs younger cohorts.
Why the study?
Catheter ablation is increasingly used for rhythm control in AF, but evidence regarding its efficacy and safety in very elderly patients remains limited.
Does first catheter ablation for atrial fibrillation provide similar 12-month freedom from documented arrhythmia recurrence and periprocedural safety in very elderly patients (aged ≥75 years) compared to patients aged 65–74 years?
Cohort (n=494)
No
Does first catheter ablation for atrial fibrillation provide similar 12-month freedom from documented arrhythmia recurrence and periprocedural safety in very elderly patients (aged ≥75 years) compared to patients aged 65–74 years?
In selected elderly patients undergoing first AF ablation, 12-month arrhythmia-free survival and periprocedural complication rates did not significantly differ between very elderly patients (≥75 years) and younger elderly cohorts (65–74 years), nor between radiofrequency and cryoballoon modalities.
Answers are grounded in this paper and cite their sources.
May support AF ablation in selected patients ≥75 years; leaves open need for randomized confirmation of age-independent efficacy.
Background Catheter ablation is increasingly used for rhythm control in atrial fibrillation (AF), but evidence in very elderly patients remains limited. Methods We retrospectively studied consecutive patients aged ≥65 years undergoing first AF ablation between 2018 and 2022. Effectiveness was evaluated in 457 patients with evaluable post-discharge rhythm follow-up, whereas periprocedural safety was evaluated in all 494 otherwise eligible patients with ascertainable inpatient safety outcomes. Outcomes were compared among patients aged ≥75 years, 70–74 years, and 65–69 years. Radiofrequency ablation (RFCA) and cryoballoon ablation (CBA) were compared descriptively among patients aged ≥75 years. Results Of 457 patients included in the effectiveness analysis, 82 were aged ≥75 years, 123 aged 70–74 years, and 252 aged 65–69 years. The corresponding 12-month Kaplan–Meier estimates of freedom from documented recurrence were 80.72%, 66.77%, and 73.38% (95% CIs 70.04%–87.91%, 57.42%–74.52%, and 67.35%–78.48%, respectively; log-rank P = 0.096). Age group was not associated with documented recurrence in the main adjusted analysis (overall age-group P = 0.152). Among 494 patients in the safety analysis, the composite periprocedural safety endpoint occurred in 7.87%, 3.73%, and 3.69%, respectively (P = 0.240). In the descriptive ≥75-year subgroup comparison, the 12-month Kaplan–Meier estimates were 72.97% for RFCA and 85.53% for CBA (95% CIs 53.09%–85.48% and 71.98%–92.84%, respectively; log-rank P = 0.220); complication rates were 4/35 (11.43%) and 3/54 (5.56%), respectively (P = 0.427). Conclusion In this single-center cohort of older patients who were considered suitable for and underwent first catheter ablation for AF, no statistically significant differences were detected in 12-month freedom from documented atrial tachyarrhythmia recurrence or periprocedural complication rates across age groups, or between RFCA and CBA among patients aged 75 years or older. However, the modest sample size and limited number of events reduced precision, and generalizability to the broader population of older patients with AF is uncertain.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) conducted a cohort in Atrial fibrillation (n=494). Age ≥75 years undergoing first AF catheter ablation vs. Age 65-69 years (and 70-74 years) was evaluated on 12-month freedom from documented atrial tachyarrhythmia recurrence (p=0.096). Catheter ablation for AF in patients aged ≥75 vs 70-74 and 65-69 years showed similar 12-month freedom from recurrence and complication rates.
Synapse has enriched 10 related papers. Consider them for comparative context: